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third-generation cephalosporins has become a major clinical concern worldwide. The aims of this study were to determine 
the prevalence of pAmpC-producing E. cloacae isolates and typing of them in Qazvin and Tehran provinces, Iran.
 A total of 120 cefoxitin non-susceptible isolates of E. cloacae were obtained from educational hos-
Susceptibility to cefoxitin was determined by Kirby-Bauer disk diffusion method. PCR and sequencing were employed to 
detect pAmpC families’ genes (ACC, FOX, MOX, DHA, CIT and EBC) and the clonal relatedness of pAmpC-positive iso-
lates was evaluated by enterobacterial repetitive intergenic consensus (ERIC)-PCR method.
In total, 20 (16.7%) isolates of E. cloacae were positive for presence of pAmpC genes among those bla
DHA-1
(14.2%) 
was the most common gene followed by bla
CMY-2
 (2.5%). Results of ERIC-PCR showed that that the prevalence of DHA-1
and CMY-2-producing E. cloacae isolates was not due to clonal outbreaks.
E. cloacae 
isolates in Iran. The appearance of pAmpC should be considered as a warning for the implementation of appropriate infection 
control and therapeutic policies in order to prevent the dissemination of these resistant organisms in our hospital settings.
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Enterobacter cloacae is a prevalent opportunistic 
pathogen which is associated with nosocomial infec-
tion in hospital settings (1). The most common caus-
ing infections of this organism are the urinary tract, 
lower respiratory tract, skin and soft tissue, and cen-
one of the most prescribed choices against bacterial 
bacteria, such as Enterobacteriaceae and Pseudomo-
nas aeruginosa (4). In recent years, emerging of new-
-
complicates the process of therapy and limits treat-
ment options (4, 5). The extensive and inappropriate 
appearance of these resistant determinants, especial-
ly when third-generation cephalosporins are used to 
treat serious infections (6).
-
